In immune checkpoint analysis, three immune checkpoint genes (HAVCR2, PDCD1LG2, SIGLEC15) were significantly different between high and low-risk groups of BLCA and normal adjacent tissues. The gene discussed is HAVCR2; the disease is bladder transitional cell carcinoma.